AOL Money & Finance

Analyst downgrades: MRK, AZN, MI, ONT and ZION

Posted Jul 7th 2008 11:44AM by Laurie PasternackLaurie Pasternack RSS Feed
Filed under: Analyst reports, Analyst upgrades and downgrades, Merck and Co (MRK)

More

MOST NOTEWORTHY: Merck, On2 Technologies and Zions Bancorp were today's noteworthy downgrades:
  • UBS downgraded Merck & Co Inc (NYSE: MRK) to Neutral from Buy citing slowing Gardasil trends and vaccine supply issues.
  • Merriman cut On2 Technologies Inc (AMEX: ONT) to Neutral from Buy to reflect the reduced visibility into financials and management changes.
  • Baird downgraded shares of Zions Bancorporation (NASDAQ: ZION) to Neutral from Outperform to reflect deteriorating credit quality and growing capital concerns. The firm lowered their target price to $32 from $43.
OTHER DOWNGRADES:

Tags: Acme Packet, AcmePacket, APKT, AstraZeneca, AZN, downgrades, Gardasil, inthenews, Marshall Ilsley, MarshallIlsley, Merck, Merck co, MerckCo, MI, MRK, On2, On2 Tech, On2 Technologies, On2Tech, On2Technologies, ONT, ZION, ZIons Bancorp, ZionsBancorp

Symbol Lookup
IndexesChangePrice
DJIA-14.2810,318.16
NASDAQ-10.782,146.04
S&P 500-3.521,091.38

Last updated: November 22, 2009: 10:30 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    • My Portfolio
    • Create a New Portfolio

    BloggingStocks Partners

    More from AOL Money & Finance

    WalletPop Headlines